KRT9 gene mutation spectrum analysis and prenatal DNA diagnosis in five epidermolytic palmoplantar keratoderma pedigrees

Li-qun XU,Yan-fang WANG,Yue-xiao TANG,Xiao-rui LUAN,Ping YU,Xian-ning ZHANG
DOI: https://doi.org/10.13404/j.cnki.cjbhh.2017.09.013
2017-01-01
Abstract:Objective:To investigate the KRT9 gene mutation spectrum of five epidermolytic palmoplantar keratoderma (EPPK) pedigrees,and to perform the prenatal DNA diagnosis at the request of 3 families.Methods:Venous blood of the family members was collected,and genomic DNA was purified.After amplifying the sequences of all 7 coding exons and their adjacent DNA regions by PCR,Sanger sequencing was performed to reveal the potential KRT9 mutant.Then,AS-PCR was carried out to verify the mutation.For prenatal DNA diagnosis,amniotic fluid was collected from the pregnant woman in the pedigree first,then fetal genomic DNA was extracted.PCR,Sanger sequencing and AS-PCR were used to test the genotype of the fetus.Results:Among 5 EPPK pedigrees,c.487C>T (p.Arg163Trp),the most common heterogenous mutant in KRT9,was found in 2 pedigrees;other heterogenous mutants were c.482A>G (p.Asn161Ser),c.488G>A (p.Arg163Gln) and c.566A>G (p.Tyr167Cys),respectively.Unfortunately,the results of prenatal DNA diagnosis showed that fetuses from the three families had the corresponding KRT9 mutation.Conclusions:For the suspected EPPK patient and his or her family,KRT9 gene testing can be applied rapidly to help the clinical precision diagnosis.Once the KRT9 mutant was identified,amniocentesis or preimplantation genetic diagnosis (PGD) could be used to predict the status of fetus in the family in order to realize birth health.
What problem does this paper attempt to address?